Surgery
Volume 144, Issue 4 , Pages 606-610 , October 2008

The use of radioisotope combined with isosulfan blue dye is not superior to radioisotope alone for the identification of sentinel lymph nodes in patients with breast cancer

  • Steven Bines, MD

      Affiliations

    • Department of General Surgery, Rush University Medical Center, Chicago, IL
    • Corresponding Author InformationReprint requests: Steven D. Bines, MD, Department of General Surgery, Rush University Medical Center, 1653 West Congress Parkway, Chicago, IL 60612.
    • ,
  • Katherine Kopkash, MD

      Affiliations

    • Department of General Surgery, Rush University Medical Center, Chicago, IL
    • ,
  • Amjad Ali, MD

      Affiliations

    • Department of Nuclear Medicine, Rush University Medical Center, Chicago, IL
    • ,
  • Louis Fogg, PhD

      Affiliations

    • Department of Rush University School of Nursing, Rush University Medical Center, Chicago, Ill
    • ,
  • Norman Wool, MD

      Affiliations

    • Department of General Surgery, Rush University Medical Center, Chicago, IL

,Accepted 19 June 2008.

References 

  1. Silverstein MJ, Skinner KA, Lomis TJ. Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg. 2001;25:767–772
  2. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;2:335–339
  3. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. A randomized comparison of sentinel node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546–553
  4. Krag DN, Julian TB, Harlow SP, Weaver DL, Ashikaga T, Bryant J, et al. NSABP-32: phase III, randomized trial comparing axillary resection with sentinel lymph node resection: a description of the trial. Ann Surg Oncol. 2004;11(3 Suppl):208S–210S
  5. American Cancer Society National Comprehensive Cancer Network Guidelines. www.nccn.org/professionals/physician_gls/default.asp.
  6. Lyman GH, Giuliano AE, Somerfield MR, Benson AB, Bodurka DC, Burstein HJ, et al. American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer. J Clin Oncol. 2005;23:7703–7720
  7. Scherer K, Studer W, Figueiredo V, Bircher AJ. Anaphylaxis to isosulfan blue and cross-reactivity to patent blue V: case report and review of the nomenclature of vital blue dyes. Ann Allergy Asthma Immunol. 2006;96:497–500
  8. Amr D, Broderick-Villa G, Haigh PI, Guenther JM, Difronzo LA. Adverse drug reactions during lymphatic mapping and sentinel lymph node biopsy for solid neoplasms. Am Surg. 2005;71:720–724
  9. Raut CP, Hunt KK, Akins JS, Daley MD, Ross MI, Singletary SE, et al. Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: results of a surgical prospective clinical practice protocol. Cancer. 2005;104:692–699
  10. Heinle E, Burdumy T, Recabaren J. Factitious oxygen desaturation after isosulfan blue injection. Am Surg. 2003;69:899–901
  11. Pinero A, Illana J, Garcia-Palenciano C, Canizares F, Canteras M, Canadillas V, et al. Effect on oximetry of dyes used for sentinel lymph node biopsy: are there differences?. Arch Surg. 2004;139:1204–1207
  12. Raut CP, Daley MD, Hunt KK, Akins J, Ross MI, Singletary SE, et al. Anaphylactoid reactions to isosulfan blue dye during breast cancer lymphatic mapping in patients given preoperative prophylaxis. J Clin Oncol. 2004;22:567–568
  13. King TA, Fey JV, Van Zee KJ, Jeert AS, Gemignani ML, Port ER, et al. A prospective analysis of the effect of blue-dye volume on sentinel lymph node mapping success and incidence of allergic reaction in patients with breast cancer. Ann Surg Oncol. 2004;11:535–541
  14. Golshan M, Nakhlis F. Can methylene blue only be used in sentinel lymph node biopsy for breast cancer?. Breast J. 2006;12:428–430
  15. Stradling B, Aranha G, Gabram S. Adverse skin lesions after methylene blue injections for sentinel lymph node localization. Am J Surg. 2002;184:350–352
  16. Degnim AC, Oh K, Cimmino VM, Diehl KM, Chang AE, Newman LA, et al. Is blue dye indicated for sentinel lymph node biopsy in breast cancer patients with a positive lymphoscintigram?. Ann Surg Oncol. 2005;12:712–717
  17. Derossis AM, Fey J, Yeung H, Yeh SD, Heerdt AS, Petrek J, et al. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg. 2001;193:473–478
  18. Kern KA. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid. J Am Coll Surg. 2002;195:467–475
  19. Lin KM, Patel TH, Ray A, Ota M, Jacobs L, Kuvshinoff B, et al. Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes. J Am Coll Surg. 2004;199:561–566
  20. Zavagno G, Rubello D, Franchini Z, Meggiolaro F, Ballarin A, Casara D, et al. Axillary sentinel lymph nodes in breast cancer: a single lymphatic pathway drains the entire mammary gland. Eur J Surg Oncol. 2005;31:479–484
  21. Kargozaran H, Shah M, Li Y, Beckett L, Gandour-Edwards R, Schneider PD, et al. Concordance of peritumoral technetium 99M colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy. J Surg Res. 2007;143:126–129
  22. Hung WK, Chan CM, Ying M, Chong SF, Mak KL, Yip AW. Randomized clinical trial comparing blue dye with combined dye and isotope for sentinel lymph node biopsy in breast cancer. Br J Surg. 2005;92:1494–1497
  23. Morrow M, Rademaker AW, Bethke KP, Talamonti MS, Dawes LG, Clausen J, et al. Learning sentinel node biopsy: Results of a prospective randomized trial of two techniques. Surgery. 1999;126:714–722
  24. Newman LA. Lymphatic mapping and sentinel lymph node biopsy in breast cancer patients: A comprehensive review of variations in performance and technique. J Am Coll Surg. 2004;199:804–816
  25. Newman EA, Newman LA. Lymphatic mapping techniques and sentinel lymph node biopsy in breast cancer. Surg Clin N Am. 2007;87:353–364

 Presented at the 65th Annual Meeting of the Central Surgical Association, Cincinnati, Ohio, March 6–8, 2008.

PII: S0039-6060(08)00425-X

doi: 10.1016/j.surg.2008.06.023

Surgery
Volume 144, Issue 4 , Pages 606-610 , October 2008

Article Tools